Ronan at 2 years old. "I know Ronan's purpose in life was to shed light on this disease," says his mother, Maya Thompson. "This is why I will continue to fight for childhood cancer for the rest of my life."
Kristen Miller, a colonoscopy patient, sits with Dr. Stephen Hanauer at the University of Chicago Medical Center in Chicago in 2010. They're looking at an interactive computer program describing benefits and risks of the procedure.
Credit Brian Kersey / AP
Turn 50, and you can pretty much count on an invitation to join the AARP and a referral to the gastroenterologist to be screened for colon cancer.
Two-thirds or less of people ages 50-75, the target range for colorectal cancer screening, are up-to-date on testing, according to the Centers of Disease Control and Prevention.
That's better than it used to be, but still isn't up to par. The national screening goal is 70.5 percent of eligible people in 2020.
It's a startling trend: Many women with cancer in one breast are choosing to have their healthy breast removed, too.
But a study being presented later this week says more than three-quarters of women who opt for double mastectomies are not getting any benefit because their risk of cancer developing in the healthy breast is no greater than in women without cancer.
The endless debate over routine mammograms is getting another kick from an analysis that sharply questions whether the test really does what it's supposed to.
Dr. H. Gilbert Welch, coauthor of the analysis of mammography's impact, which was just published in The New England Journal of Medicine, tell Shots that the aim was to "get down to a very basic question."